Sorna Corporation Is Set for a 47% Correction as Speculation Meets Reality
By stockpickr AI | March 10, 2026 | 10 min read
Investment Summary
Sorna Corporation provides medical imaging and diagnostic solutions. Market sentiment remains speculative due to limited trading volume.
Investment Recommendation
Sell
Fair Value: $6.58
Current Price: $12.45
Upside/Downside: -47.1%
SORN operates as a small-cap entity with limited financial transparency. Investors should exercise extreme caution due to low liquidity and lack of institutional interest.
Key Metrics
- Market Cap: $12.45M
- P/E Ratio: N/A
- Dividend Yield: 0%
- Analyst Target Price: $0.02
Strengths
- Niche focus on medical imaging archiving
- Low valuation relative to some tech peers
- Establishment in specialized healthcare data
Risk Factors
- Extremely low liquidity and trading volume
- Lack of consistent analyst coverage
- Regulatory risks in medical data handling
Latest News
Sorna Corporation Disclosures
Routine submission of regulatory filings and corporate updates for the OTC market.
Source: OTC Markets | Sentiment: Neutral